Pancreatic Cancer Clinical Trials in San Francisco

Showing 81-84 of 84 trials

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

NCT00326911

Eligible patients with metastatic pancreatic cancer will be treated with dual agent monoclonal antibody consisting of cetuximab and bevacizumab alone or in combination with gemcitabine

Metastatic Pancreatic Cancer

Eli Lilly and Company61 participantsStarted May 2006

Jonesboro, Arkansas, United States • San Francisco, California, United States • Stamford, Connecticut, United States +13 more locations

COMPLETEDPhase 228 miles

Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer

NCT00233415

The purpose of the trial is to test the efficacy of combining conventional chemoradiotherapy with radiosurgery for locally advanced pancreas cancer.

Pancreatic Cancer

Stanford University100 participantsStarted Jul 2003

Stanford, California, United States

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer

Pancreatic Cancer Trials in Other Cities

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Other Conditions in San Francisco